• Route

  • Cluster question

  • Organisation

Research initiatives

PM.20.056 – Optimal survival and quality of life in metastatic colorectal cancer with irinotecan dosing based on UGT1A1 genotype and gut microbiome enzyme activity including a dietary intervention

Route: Personalised medicine: the individual at the centre

cluster question: 095 How can we personalise health care, for example by using biomarkers?

Problem description: Irinotecan-based systemic therapy is one of the main chemotherapeutic agents used for metastatic colorectal cancer (mCRC). It can […]

View the initiative

PM.20.045 – Next generation immunodermatology

Route: Personalised medicine: the individual at the centre

cluster question: 095 How can we personalise health care, for example by using biomarkers?

Until recently, Dermatology has been neglected from therapeutics development resulting in a high unmet need for many skin diseases. As […]

View the initiative

PM.20.047 – 4D skeletal surgery twin

Route: Personalised medicine: the individual at the centre

cluster question: 095 How can we personalise health care, for example by using biomarkers?

The project ‘4D skeletal surgery twin’ aims at the improvement of personalized skeletal health. Degenerative diseases such as cancer, rheumatic […]

View the initiative